Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127496421 | 12749642 | 1 | I | 20160714 | 20160912 | 20160916 | 20160916 | EXP | US-AMGEN-USACT2016123686 | AMGEN | 67.00 | YR | E | M | Y | 104.30000 | KG | 20160916 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127496421 | 12749642 | 1 | PS | carfilzomib | CARFILZOMIB | 1 | Intravenous (not otherwise specified) | 36 MG/M2, PER CHEMO REGIM | 202714 | 36 | MG/M**2 | INTRAVENOUS INFUSION | |||||||
| 127496421 | 12749642 | 2 | SS | rituximab | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 375 MG/M2, PER CHEMO REGIM | 0 | 375 | MG/M**2 | INJECTION | |||||||
| 127496421 | 12749642 | 3 | SS | lenalidomide | LENALIDOMIDE | 1 | Oral | 15 MG, PER CHEMO REGIM | 0 | 15 | MG | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127496421 | 12749642 | 1 | Mantle cell lymphoma |
| 127496421 | 12749642 | 2 | Mantle cell lymphoma |
| 127496421 | 12749642 | 3 | Mantle cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127496421 | 12749642 | HO |
| 127496421 | 12749642 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127496421 | 12749642 | Cardiac disorder | |
| 127496421 | 12749642 | Dyspnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |